Advertisement
BIIB vs BYFC
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIIB is a Buy and BYFC is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BIIB’s FA Score shows that 0 FA rating(s) are green whileBYFC’s FA Score has 0 green FA rating(s).
- BIIB’s FA Score: 0 green, 5 red.
- BYFC’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BIIB’s TA Score shows that 5 TA indicator(s) are bullish while BYFC’s TA Score has 4 bullish TA indicator(s).
- BIIB’s TA Score: 5 bullish, 3 bearish.
- BYFC’s TA Score: 4 bullish, 5 bearish.
Price Growth
BIIB (@Pharmaceuticals: Major) experienced а -5.18% price change this week, while BYFC (@Regional Banks) price change was +6.32% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.01%. For the same industry, the average monthly price growth was -0.04%, and the average quarterly price growth was +10.01%.
The average weekly price growth across all stocks in the @Regional Banks industry was -0.54%. For the same industry, the average monthly price growth was +4.33%, and the average quarterly price growth was +10.21%.
Reported Earning Dates
BIIB is expected to report earnings on Oct 22, 2025.
BYFC is expected to report earnings on Mar 31, 2025.
Industries' Descriptions
@Pharmaceuticals: Major (+1.01% weekly)The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
@Regional Banks (-0.54% weekly)Regional banks have a smaller reach than major banks, and cater mostly to one region of a country, such as a state or within a group of states. They offer services often similar – albeit with some limitations/smaller scale – compared to major banks. Taking deposits, making loans, mortgages, leases, credit cards , fund management, insurance and investment banking. SunTrust Banks, State Street Corp., M&T Bank Corp. are some examples of U.S. regional banks.
| BIIB | BYFC | BIIB / BYFC | |
| Capitalization | 31.3B | 51.1M | 61,252% |
| EBITDA | 2.04B | N/A | - |
| Gain YTD | -16.623 | 17.810 | -93% |
| P/E Ratio | 26.95 | 10.21 | 264% |
| Revenue | 9.84B | 34.4M | 28,593% |
| Total Cash | 1.05B | 6.19M | 16,957% |
| Total Debt | 7.34B | 224M | 3,276% |
BIIB | BYFC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 59 | 80 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | 91 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 77 | |
PRICE GROWTH RATING 1..100 | 60 | 41 | |
P/E GROWTH RATING 1..100 | 100 | 1 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BIIB's Valuation (50) in the Biotechnology industry is somewhat better than the same rating for BYFC (91) in the Savings Banks industry. This means that BIIB’s stock grew somewhat faster than BYFC’s over the last 12 months.
BIIB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BYFC (100) in the Savings Banks industry. This means that BIIB’s stock grew similarly to BYFC’s over the last 12 months.
BYFC's SMR Rating (77) in the Savings Banks industry is in the same range as BIIB (100) in the Biotechnology industry. This means that BYFC’s stock grew similarly to BIIB’s over the last 12 months.
BYFC's Price Growth Rating (41) in the Savings Banks industry is in the same range as BIIB (60) in the Biotechnology industry. This means that BYFC’s stock grew similarly to BIIB’s over the last 12 months.
BYFC's P/E Growth Rating (1) in the Savings Banks industry is significantly better than the same rating for BIIB (100) in the Biotechnology industry. This means that BYFC’s stock grew significantly faster than BIIB’s over the last 12 months.
| BIIB | BYFC | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 84% |
| Stochastic ODDS (%) | 1 day ago 68% | 2 days ago 79% |
| Momentum ODDS (%) | 1 day ago 53% | 2 days ago 81% |
| MACD ODDS (%) | 1 day ago 51% | 2 days ago 80% |
| TrendWeek ODDS (%) | 1 day ago 70% | 2 days ago 79% |
| TrendMonth ODDS (%) | 1 day ago 70% | 2 days ago 76% |
| Advances ODDS (%) | 14 days ago 54% | N/A |
| Declines ODDS (%) | 1 day ago 70% | 6 days ago 78% |
| BollingerBands ODDS (%) | 1 day ago 58% | 2 days ago 74% |
| Aroon ODDS (%) | 1 day ago 36% | 2 days ago 74% |
Advertisement
BYFC and
Correlation & Price change
A.I.dvisor tells us that BYFC and FITB have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BYFC and FITB's prices will move in lockstep.
| Ticker / NAME | Correlation To BYFC | 1D Price Change % | ||
|---|---|---|---|---|
| BYFC | 100% | +12.08% | ||
| FITB - BYFC | 28% Poorly correlated | -2.24% | ||
| KEY - BYFC | 28% Poorly correlated | -2.56% | ||
| FITBI - BYFC | 27% Poorly correlated | -0.08% | ||
| HBAN - BYFC | 27% Poorly correlated | -2.99% | ||
| COLB - BYFC | 26% Poorly correlated | -4.41% | ||
More | ||||